Issues with AQP4 are associated with AD pathology and cognitive function, suggesting that AQP4 localization may be a key driver in disease progression (Wilcock et al., 2009; Zeppenfeld et al., 2017; Simon et al., 2022). This evidence concerns the gene AQP4 and Alzheimer disease.